Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 4, 2004 - Issue 6
Submit an article Journal homepage
365
Views
19
CrossRef citations to date
0
Altmetric
Editorial

Immunome-derived vaccines

Anne S De Groot Brown University, TB/HIV Research Laboratory, Providence, RI 02912, USA and Epivax, Inc., Providence, Rhode Island 02903, USA. [email protected]
Pages 767-772 | Published online: 23 Feb 2005

Bibliography

  • RAPPUOLI R, COVACCI A: Reverse vaccinology and genomics. Science (2003) 302(5645):602.
  • PETROVSKY N, BRUSIC V: Computational immunology: the coming of age. Immunol Cell Biol. (2002) 80(3):248–254.
  • PEDERSON T: The immunome. MM. Immunol. (1999) 36(15-16):1127–1128.
  • DOYTCHINOVA IA, TAYLOR P, FLOWER DR: Proteomics in vaccinology and immunobiology: an informatics perspective of the immunone. Biomed. Biotechnol (2003) 2003(5):267–290.
  • DE GROOT AS, MARTIN B: From immunome to vaccine: epitope mapping and vaccine design tools. Novartis Found. Symp. (2003) 254:57–72.
  • JONGENEEL V: Towards a cancer immunome database. Cancer Immun. (2001) 1:3.
  • KLADE CS: Proteomics approaches towards antigen discovery and vaccine development. Curc Opin. Mol. Ther. (2002) 4(3):216–223.
  • FRASER CK, EISEN JA, SALZBERG SL: Microbial genome sequencing. Nature (2000) 406:799–803.
  • MENNE KM, HERMJAKOB H, APWEILER RA: Comparison of signal sequence prediction methods using a test set of signal peptides. Bioinformatics (2000) 16(8):741–742.
  • SUHAN ML, HOVDE CJ: Disruption of an internal membrane-spanning region in Shiga toxin 1 reduces cytotoxicity. Infect. Immun. (1998) 66(11):5252–5259.
  • FALQUET L, PAGNI M, BUCHER P et al.: The PROSITE database, its status in 2002. Nucleic Acids Res. (2002) 30(1):235–238.
  • ZAGURSKY RJ, OLMSTED SB, RUSSELL DP, WOOTERS JL: Bioinformatics: how it is being used to identify bacterial vaccine candidates. Expert Rev Vaccines (2003) 2(3):417–436.
  • CHAKRAVARTI DN, FISKE MJ, FLETCHER LD, ZAGURSKY RJ: Application of genomics and proteomics for identification of bacterial gene products as potential vaccine candidates. Vaccine (2000) 19(6):601–612.
  • DE GROOT AS, SBAI H, SAINT AUBIN C, MCMURRY JA, MARTIN W: Immuno-informatics: mining the genome for vaccine components. Immunol Cell Biol. (2002) 80:255–269.
  • DE GROOT AS, MARTIN W: From immunome to vaccine: epitope mapping and vaccine design tools. Novartis Foundation Symposium No. 254. 10–12 October 2002 (2003).
  • DHIMAN N, BONILLA R, O'KANE DJ, POLAND GA: Gene expression microarrays: a 21st century tool for directed vaccine design. Vaccine (2001) 20(1-2):22–30.
  • BEHR MA, WILSON MA, GILL WP et al.: Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science (1999) 284(5419):1520–1523.
  • RAPPUOLI R: Reverse vaccinology, a genome-based approach to vaccine development. Vaccine (2001) 19(17-19):2688–2691.
  • ADAMOU JE, HEINRICHS JH, ERWIN AL et al.: Identification and characterization of a novel family of pneumococcal proteins that are protective against sepsis. Infect. Inman. (2001) 69(2):949–958.
  • WEICHHART T, HORKY M, SOLLNER J et al.: Functional selection of vaccine candidate peptides from Staphylococcus aureuswhole-genome expression libraries M vitro. Infect. Immun. (2003) 71(8):4633–4641.
  • ETZ H, MINH DB, HENICS T et al: Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureus. Proc. Natl. Acad. Sci. USA (2002) 99(10):6573–6578.
  • ROSS BC, CZAJKOWSKI L, HOCKING D et al.: Identification of vaccine candidate antigens from a genomic analysis of Porphyromonas gingivalis. Vaccine (2001) 19(30):4135–4142.
  • TETTELIN H, MASIGNANI V, CIESLEWICZ MJ et al.: Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae. Proc. Nati Acad. Sci. USA (2002) 99:12391–12396.
  • MONTIGIANI S, FALUGI F, SCARSELLI M et al.: Genomic approach for analysis of surface proteins in Chlamydia pneumoniae. Infect. Immun. (2002) 70(1):368–379.
  • MATHIASSEN S, LAUEMOLLER SL, RUHWALD M, CLAESSON MH, BUUS S: Tumor-associated antigens identified by mRNA expression profiling induce protective anti-tumor immunity. Eur. Immunol. (2001) 31(4):1239–1246.
  • ROBINSON WH, GARREN H, UTZ PJ, STEINMAN L: Millennium Award. Proteomics for the development of DNA tolerizing vaccines to treat autoimmune disease. Clin. Immunoi (2002) 103(1):7–12.
  • MARRA MA, JONES SJ, ASTELL CR et al: The genome sequence of the SARS-associated coronavirus. Science (2003) 300(5624):1399–1404.
  • ROTA PA, OBERSTE MS, MONROE SS et al.: Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science (2003) 300(5624):1394–1399.
  • IMLER JL, HOFFMANN JA: Toll receptors in innate immunity. Trends Cell Biol. (2001) 11(7):304–311.
  • ENSHELL-SEIJFFERS D, DENISOV D, GROISMAN B et al.: The mapping and reconstitution of a conformational discontinuous B-cell epitope of HIV–1.

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.